Advertisement
Screener

INOVIO PHARMACEUTICALS, INC. (INO) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

INOVIO PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)

INOVIO PHARMACEUTICALS, INC. (INO) reported Basic Shares Outstanding (Weighted Average) of 81.62 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12

  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 81.62M shares, a 110.20% increase year-over-year.
  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 69.10M shares, a 78.96% increase year-over-year.
  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 62.03M shares, a 106.82% increase year-over-year.
  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 52.17M shares, a 85.39% increase year-over-year.
  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 46.89M shares, a 72.62% increase from fiscal 2024.
  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 27.16M shares, a 22.49% increase from fiscal 2023.
  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 22.17M shares, a 11.51% increase from fiscal 2022.
  • INOVIO PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 19.89M shares, a 14.27% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-3081.62M shares
10-Q · filed 2026-08-12
75.40M shares
10-Q · filed 2026-08-12
70.92M shares
derived: average of 3 quarters · filed 2026-08-12
66.23M shares
derived: average of 4 quarters · filed 2026-08-12
2026-03-3169.10M shares
10-Q · filed 2026-05-13
65.57M shares
derived: average of 2 quarters · filed 2026-05-13
61.10M shares
derived: average of 3 quarters · filed 2026-05-13
55.53M shares
derived: average of 4 quarters · filed 2026-08-12
2025-12-3162.03M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
57.10M shares
derived: average of 2 quarters · filed 2026-03-12
51.01M shares
derived: average of 3 quarters · filed 2026-08-12
46.89M shares
10-K · filed 2026-03-12
2025-09-3052.17M shares
10-Q · filed 2025-11-10
45.50M shares
derived: average of 2 quarters · filed 2026-08-12
41.84M shares
10-Q · filed 2025-11-10
39.90M shares
derived: average of 4 quarters · filed 2026-08-12
2025-06-3038.83M shares
10-Q · filed 2026-08-12
38.72M shares
10-Q · filed 2026-08-12
35.81M shares
derived: average of 3 quarters · filed 2026-08-12
33.89M shares
derived: average of 4 quarters · filed 2026-08-12
2025-03-3138.61M shares
10-Q · filed 2026-05-13
34.30M shares
derived: average of 2 quarters · filed 2026-05-13
32.25M shares
derived: average of 3 quarters · filed 2026-05-13
30.99M shares
derived: average of 4 quarters · filed 2026-05-13
2024-12-3129.99M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
29.07M shares
derived: average of 2 quarters · filed 2026-03-12
28.44M shares
derived: average of 3 quarters · filed 2026-03-12
27.16M shares
10-K · filed 2026-03-12
2024-09-3028.14M shares
10-Q · filed 2025-11-10
27.67M shares
derived: average of 2 quarters · filed 2025-11-10
26.22M shares
10-Q · filed 2025-11-10
25.34M shares
derived: average of 4 quarters · filed 2025-11-10
2024-06-3027.20M shares
10-Q · filed 2025-08-12
25.24M shares
10-Q · filed 2025-08-12
24.41M shares
derived: average of 3 quarters · filed 2025-08-12
23.90M shares
derived: average of 4 quarters · filed 2025-08-12
2024-03-3123.29M shares
10-Q · filed 2025-05-13
23.01M shares
derived: average of 2 quarters · filed 2025-05-13
22.80M shares
derived: average of 3 quarters · filed 2025-05-13
22.61M shares
derived: average of 4 quarters · filed 2025-05-13
2023-12-3122.73M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
22.56M shares
derived: average of 2 quarters · filed 2025-03-18
22.38M shares
derived: average of 3 quarters · filed 2025-03-18
22.17M shares
10-K · filed 2025-03-18
2023-09-3022.39M shares
10-Q · filed 2024-11-14
268.62M shares
10-Q · filed 2023-11-09
22.21M shares
derived: average of 2 quarters · filed 2024-11-14
21.99M shares
10-Q · filed 2024-11-14
263.84M shares
10-Q · filed 2023-11-09
-139.60M shares
derived: average of 4 quarters · filed 2024-11-14
2023-06-3022.03M shares
10-Q · filed 2024-08-08
264.35M shares
10-Q · filed 2023-08-09
21.78M shares
10-Q · filed 2024-08-08
261.41M shares
10-Q · filed 2023-08-09
-193.60M shares
derived: average of 3 quarters · filed 2024-08-08
-82.86M shares
derived: average of 4 quarters · filed 2024-08-08
2023-03-3121.54M shares
10-Q · filed 2024-05-13
258.44M shares
10-Q · filed 2023-05-10
-301.41M shares
derived: average of 2 quarters · filed 2024-05-13
-117.83M shares
derived: average of 3 quarters · filed 2024-05-13
-29.55M shares
derived: average of 4 quarters · filed 2024-05-13
2022-12-31-624.36M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-187.51M shares
derived: average of 2 quarters · filed 2024-03-06
-46.58M shares
derived: average of 3 quarters · filed 2024-03-06
19.89M shares
10-K · filed 2024-03-06
238.62M shares
10-K · filed 2023-03-01
2022-09-30249.35M shares
10-Q · filed 2023-11-09
242.31M shares
derived: average of 2 quarters · filed 2023-11-09
234.63M shares
10-Q · filed 2023-11-09
37.70M shares
derived: average of 4 quarters · filed 2024-03-06
2022-06-30235.28M shares
10-Q · filed 2023-08-09
227.15M shares
10-Q · filed 2023-08-09
-32.85M shares
derived: average of 3 quarters · filed 2024-03-06
27.94M shares
derived: average of 4 quarters · filed 2024-03-06
2022-03-31218.94M shares
10-Q · filed 2023-05-10
-166.91M shares
derived: average of 2 quarters · filed 2024-03-06
-41.17M shares
derived: average of 3 quarters · filed 2024-03-06
21.51M shares
derived: average of 4 quarters · filed 2024-03-06
2021-12-31-552.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-171.23M shares
derived: average of 2 quarters · filed 2024-03-06
-44.30M shares
derived: average of 3 quarters · filed 2024-03-06
17.40M shares
10-K · filed 2024-03-06
208.83M shares
10-K · filed 2022-03-01
2021-09-30210.30M shares
10-Q · filed 2022-11-08
209.93M shares
derived: average of 2 quarters · filed 2022-11-08
207.46M shares
10-Q · filed 2022-11-08
199.20M shares
derived: average of 4 quarters · filed 2023-03-01
2021-06-30209.56M shares
10-Q · filed 2022-08-09
206.01M shares
10-Q · filed 2022-08-09
195.50M shares
derived: average of 3 quarters · filed 2023-03-01
187.97M shares
derived: average of 4 quarters · filed 2023-03-01
2021-03-31202.41M shares
10-Q · filed 2022-05-10
188.48M shares
derived: average of 2 quarters · filed 2023-03-01
180.77M shares
derived: average of 3 quarters · filed 2023-03-01
174.53M shares
derived: average of 4 quarters · filed 2023-03-01
2020-12-31174.54M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
169.95M shares
derived: average of 2 quarters · filed 2023-03-01
165.23M shares
derived: average of 3 quarters · filed 2023-03-01
155.13M shares
10-K · filed 2023-03-01
2020-09-30165.36M shares
10-Q · filed 2021-11-09
160.58M shares
derived: average of 2 quarters · filed 2021-11-09
148.66M shares
10-Q · filed 2021-11-09
2020-06-30155.81M shares
10-Q · filed 2021-08-09
140.22M shares
10-Q · filed 2021-08-09
2019-12-31100.26M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
99.63M shares
derived: average of 2 quarters · filed 2022-03-01
99.12M shares
derived: average of 3 quarters · filed 2022-03-01
98.72M shares
10-K · filed 2022-03-01
2019-09-3099.01M shares
10-Q · filed 2020-11-09
98.55M shares
derived: average of 2 quarters · filed 2020-11-09
98.20M shares
10-Q · filed 2020-11-09
2019-06-3098.08M shares
10-Q · filed 2019-08-08
97.80M shares
10-Q · filed 2019-08-08
2018-12-3196.11M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
94.27M shares
derived: average of 2 quarters · filed 2020-03-12
93.23M shares
derived: average of 3 quarters · filed 2020-03-12
92.54M shares
10-K · filed 2020-03-12
2018-09-3092.42M shares
10-Q · filed 2019-11-12
91.79M shares
derived: average of 2 quarters · filed 2019-11-12
91.35M shares
10-Q · filed 2019-11-12
91.11M shares
derived: average of 4 quarters · filed 2020-03-12
2018-06-3091.15M shares
10-Q · filed 2019-08-08
90.80M shares
10-Q · filed 2019-08-08
90.68M shares
derived: average of 3 quarters · filed 2020-03-12
89.75M shares
derived: average of 4 quarters · filed 2020-03-12
2018-03-3190.45M shares
10-Q · filed 2018-05-09
90.44M shares
derived: average of 2 quarters · filed 2020-03-12
89.28M shares
derived: average of 3 quarters · filed 2020-03-12
85.81M shares
derived: average of 4 quarters · filed 2020-03-12
2017-12-3190.43M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
88.69M shares
derived: average of 2 quarters · filed 2020-03-12
84.26M shares
derived: average of 3 quarters · filed 2020-03-12
81.78M shares
10-K · filed 2020-03-12
2017-09-3086.95M shares
10-Q · filed 2018-11-08
81.18M shares
derived: average of 2 quarters · filed 2018-11-08
78.89M shares
10-Q · filed 2018-11-08
77.64M shares
derived: average of 4 quarters · filed 2019-03-12
2017-06-3075.41M shares
10-Q · filed 2018-08-07
74.78M shares
10-Q · filed 2018-08-07
74.54M shares
derived: average of 3 quarters · filed 2019-03-12
74.31M shares
derived: average of 4 quarters · filed 2019-03-12
2017-03-3174.15M shares
10-Q · filed 2018-05-09
74.11M shares
derived: average of 2 quarters · filed 2019-03-12
73.94M shares
derived: average of 3 quarters · filed 2019-03-12
73.69M shares
derived: average of 4 quarters · filed 2019-03-12
2016-12-3174.06M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
73.83M shares
derived: average of 2 quarters · filed 2019-03-12
73.54M shares
derived: average of 3 quarters · filed 2019-03-12
73.21M shares
10-K · filed 2019-03-12
2016-09-3073.60M shares
10-Q · filed 2017-11-08
73.28M shares
derived: average of 2 quarters · filed 2017-11-08
72.93M shares
10-Q · filed 2017-11-08
72.75M shares
derived: average of 4 quarters · filed 2017-11-08
2016-06-3072.96M shares
10-Q · filed 2016-08-08
72.59M shares
10-Q · filed 2016-08-08
72.46M shares
derived: average of 3 quarters · filed 2017-05-10
72.35M shares
derived: average of 4 quarters · filed 2017-05-10
2016-03-3172.23M shares
10-Q · filed 2017-05-10
72.21M shares
derived: average of 2 quarters · filed 2017-05-10
72.15M shares
derived: average of 3 quarters · filed 2017-05-10
71.03M shares
derived: average of 4 quarters · filed 2017-05-10
2015-12-3172.19M shares
10-K · filed 2016-03-14
72.11M shares
derived: average of 2 quarters · filed 2016-11-09
70.63M shares
derived: average of 3 quarters · filed 2016-11-09
68.20M shares
10-K · filed 2018-03-14
2015-09-3072.03M shares
10-Q · filed 2016-11-09
69.84M shares
derived: average of 2 quarters · filed 2016-11-09
66.85M shares
10-Q · filed 2016-11-09
65.26M shares
derived: average of 4 quarters · filed 2016-11-09
2015-06-3067.66M shares
10-Q · filed 2016-08-08
64.20M shares
10-Q · filed 2016-08-08
63.00M shares
derived: average of 3 quarters · filed 2016-08-08
62.35M shares
derived: average of 4 quarters · filed 2016-08-08
2015-03-3160.74M shares
10-Q · filed 2016-05-09
60.68M shares
derived: average of 2 quarters · filed 2016-05-09
60.58M shares
derived: average of 3 quarters · filed 2016-05-09
60.49M shares
derived: average of 4 quarters · filed 2016-05-09
2014-12-3160.61M shares
10-K · filed 2016-03-14
60.50M shares
derived: average of 2 quarters · filed 2016-03-14
60.41M shares
derived: average of 3 quarters · filed 2016-03-14
59.13M shares
10-K · filed 2017-03-15
2014-09-3060.39M shares
10-K · filed 2016-03-14
60.31M shares
derived: average of 2 quarters · filed 2016-03-14
58.63M shares
10-Q · filed 2015-11-09
56.98M shares
derived: average of 4 quarters · filed 2016-03-14
2014-06-3060.23M shares
10-K · filed 2016-03-14
57.72M shares
10-Q · filed 2015-08-10
55.84M shares
derived: average of 3 quarters · filed 2016-03-14
53.88M shares
derived: average of 4 quarters · filed 2016-03-14
2014-03-3155.16M shares
10-K · filed 2016-03-14
53.64M shares
derived: average of 2 quarters · filed 2016-03-14
51.76M shares
derived: average of 3 quarters · filed 2016-03-14
50.07M shares
derived: average of 4 quarters · filed 2016-03-14
2013-12-3152.13M shares
10-K · filed 2015-03-16
50.06M shares
derived: average of 2 quarters · filed 2015-03-16
48.37M shares
derived: average of 3 quarters · filed 2015-03-16
46.09M shares
10-K · filed 2016-03-14
2013-09-3047.99M shares
10-K · filed 2015-03-16
46.49M shares
derived: average of 2 quarters · filed 2015-03-16
44.05M shares
10-Q · filed 2014-11-10
2013-06-3044.99M shares
10-K · filed 2015-03-16
42.05M shares
10-Q · filed 2014-08-11
2013-03-3139.04M shares
10-K · filed 2015-03-16
2012-12-3134.13M shares
10-K · filed 2015-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
MEDICINOVA INC (MNOV)United States$0.130B-6.04
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Immuneering Corp (IMRX)United States$0.113B-12.51